Hepatoprotective activity of Chhit-Chan-Than extract powder against carbon tetrachloride-induced liver injury in rats  by Lin, Yi-Chun et al.
ww.sciencedirect.com
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 2 ( 2 0 1 4 ) 2 2 0e2 2 9Available online at wjournal homepage: www.j fda-onl ine.comOriginal ArticleHepatoprotective activity of Chhit-Chan-Than
extract powder against carbon tetrachloride-
induced liver injury in ratsYi-Chun Lin a,1, Kuei-Mei Cheng b,1, Hsin-Yu Huang c,d, Pei-Yu Chao e,f,
Jin-Ming Hwang g, Hsueh-Hui Lee h,i, Cheng-You Lu j, Yung-Wei Chiu a,j,*,
Jer-Yuh Liu k,l,**
aEmergency Department, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, ROC
bDepartment of Sports Management, National Taiwan University of Physical Education and Sport, Taichung,
Taiwan, ROC
cDepartment of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan, ROC
dDepartment of Hospitality Management, Wu Feng University, Chiayi, Taiwan, ROC
eDepartment of Leisure Industry Management, National Chin-Yi University of Technology, Taichung, Taiwan, ROC
fGraduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan, ROC
gSchool of Applied Chemistry, Health Care and Management College, Chung Shan Medical University, Taichung,
Taiwan, ROC
h Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung, Taiwan, ROC
iDepartment of Clinical Laboratory, Kuang Tien General Hospital, Taichung, Taiwan, ROC
j Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC
kCenter for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC
lGraduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan, ROCa r t i c l e i n f o
Article history:
Received 29 April 2013
Received in revised form
9 July 2013
Accepted 2 September 2013
Available online 7 October 2013
Keywords:
Antioxidants
Carbon tetrachloride
Hepatoprotection* Corresponding author. Emergency Departm
** Corresponding author. Center for Molecula
E-mail addresses: hboxygen@gmail.com (
1 These authors share equal contribution
1021-9498 Copyright ª 2013, Food and Drug Ad
http://dx.doi.org/10.1016/j.jfda.2013.09.012a b s t r a c t
The capability of Chhit-Chan-Than extract powder (CCTEP, 10% aqueous Ocimum gratissimum
L. extract) to protect against carbon tetrachloride (CCl4)-induced oxidative stress and
hepatotoxicity in vivo was investigated. Wistar rats were divided into five groups. Group A
was a normal control group given only vehicle; Group B, the hepatotoxic group, was
injected intraperitoneally twice a week with repeated 8% CCl4/olive oil (0.1 mL/100 g of
body weight); Groups CeE, extract-treated groups received CCl4 and different doses of
CCTEP (100 mg/kg and 200 mg/kg) or silymarin (200 mg/kg of body weight) daily by gavage
for 8 weeks, respectively. The results showed that the CCl4-induced histopathogical
changes may be prevented by CCTEP through reducing the intercellular collogen stack,
dropping blood serum alanine aminotransferase and aspartate aminotransferase levels,
and restoring the catalase activity and glutathione content. The hepatoprotective proper-
ties were further confirmed by the marked improvement in histopathological examinationent, Tungs’ Taichung MetroHarbor Hospital, Taichung, Taiwan, ROC.
r Medicine, China Medical University Hospital, Taichung, Taiwan, ROC.
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j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 2 2 0e2 2 9 221Ocimum gratissimumOxidative stressand by quantitative steatosis-fibrosis scoring. The above results suggest that CCTEP is able
to prevent the liver inflammation and fibrosis induced by repeated CCl4 administration,
and the hepatoprotective effects might be correlated partly with its antioxidant and free
radical scavenging effects.
Copyright ª 2013, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction radical mediated acute liver injury in rats [25]. CCl4-inducedChronic liver diseases are common worldwide and are caused
by long-term exposure to toxic chemicals, drugs, alcohol, and/
or viral infection, which are characterized by a progressive
evolution from steatosis to chronic hepatitis, fibrosis,
cirrhosis, and hepatocellular carcinoma [1,2]. Iterative hepatic
injury induces chronic inflammation associatedwith dynamic
healing response, ultimately leading to cirrhosis and its life-
threatening complications [3]. In the absence of an effective
pharmacological therapy for such pathological processes, the
research of herbal drugs or plant extracts for the treatment of
liver diseases has increased all over theworld [4]. For example,
silymarin, a flavonolignan mixture of milk thistle (Silybum
marianum), is one such popular hepatoprotective herbal drug.
Silymarin exhibits significant hepatoprotective effects, which
have been well demonstrated using several in vitro and in vivo
models [5,6], and is thus often used as a standard reference in
this field. Clearly, there exists a critical need to validate the
efficacy of traditional herb medicine and plant extracts using
scientific evidence and experimental models in order to
explore novel or alternative approaches for liver diseases.
The Ocimum species are widely distributed in tropical and
subtropical regions and commonly used as a food spice and
traditional herb in many countries. Among the Ocimum spe-
cies, Ocimum gratissimum L. is a well-known medicinal plant
since ancient times. It is popularly known as Vana Tulsi in
India [7,8], Chhit-Chan-Than in Taiwan [9,10] and clove basil in
most Western countries [11]. The leaf of O. gratissimum has a
strong-smelling aromatic flavor and is rich in antioxidants
and phytoconstituents. It has been prepared in a variety of
forms for consumption and is known for its multiple phar-
macological properties including anti-inflammation [10,12],
analgesic and spasmolytic activities [13], antidiarrheal activity
[14], antitumor activity [15,16], antiviral activity [17], anti-
hyperglycemic activity [18], and improvement of phagocytic
function [19]. Our research group demonstrated the beneficial
effects of the aqueous O. gratissimum extract (OGE), which
exerts potent antioxidant action in in vitro and in vivo studies
[12,20]. Using an in vitro model, OGE also exerts hep-
atoprotective effects against oxidative stress [21]. OGE pre-
treatment, in a dose-dependent manner, restored the
decrease in cell viability in H2O2-treated human hepatoma
HepG2 cells. Herbal extracts of Ocimum species have also been
shown to inhibit liver cirrhosis using the animal models
[22,23]. Nevertheless, the in vivo hepatoprotection of OGE un-
derlying its antioxidant property remains sketchy.
Carbon tetrachloride (CCl4) is an extensively used hepato-
toxic agent in preclinical animal studies [24]. It is the best-
characterized chemical for study of xenobiotic-induced freeliver damage results in increased necrosis, steatosis, and
foamy degeneration followed by the progression of fibrosis
[26]. During hepatocellular damage, varieties of enzymes
normally located in the cytosol are released into the blood
flow, where their quantification in plasma is a useful
biomarker. The metabolism of CCl4, catalyzed by liver micro-
somal cytochrome P450, rapidly overproduces free radicals
that deplete hepatic glutathione (GSH) and initiates a chain
lipid peroxidation of the hepatocyte membrane. CCl4-induced
generation of peroxy and superoxide radicals result in the
inactivation of catalase (CAT) and superoxide dismutase.
These phenomena ultimately result in oxidative stress and
hepatocyte injuries. Liver injury induced by CCl4 is a classical
system of xenobiotic-induced hepatotoxicity and has been
used extensively for decades for the screening of anti-
hepatotoxic/hepatoprotective activities of different drugs [27].
Blocking the CCl4-induced peroxidation chain reaction that
results in hepatotoxicity is one of the potential strategies by
which functional food could exert a hepatoprotective effect.
The most remarkable pathological characteristics in the liver
of CCl4-treated animals resemble closely the processes of
chronic hepatitis and cirrhosis in human [28]. Thus, male
Wistar rats challenged by CCl4 were used as the animal model
of chemical-induced hepatotoxicity in our recent studies [20]
and also in the present study. The purpose of this project
was to evaluate the hepatoprotective effect of Chhit-Chan-Than
extract powder (CCTEP, containing 10% OGE) against acute
CCl4-induced hepatic damage.2. Methods
2.1. Preparation of extract powder and composition
analysis
The CCTEP used in this study was made with 10% aqueous
OGE and 90% dextrin as an excipient. Aqueous extract of
O. gratissimum leaf was prepared as described elsewhere
[12,16,20,21,29]. Briefly, leaves of O. gratissimum were har-
vested and washed with distilled water, followed by homog-
enization with distilled water using polytron. The
homogenatewas incubated at 95C for 1 hour and then filtered
through two layers of gauze. The filtrate was centrifuged at
20,000g at 4C for 15 minutes to remove insoluble pellets and
the supernatant was thereafter collected as OGE solution.
Subsequently, the aqueous solution was mixed with water-
soluble dextrin as an excipient. The powders obtained by
spray drying were packaged in sealed metallized bioriented
polypropylene bags at 24  2C prior to the subsequent
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determined by the FolineCiocalteau method [30,31] and
Lamaison method [32], respectively. The polyphenol content
of OGE was analyzed as previously described [12,16,20,21,29]
and revealed that the final product of CCTEP contained
1.77% polyphenolic acid and 0.69% flavonoids.2.2. Treatment of animals
Male Wistar rats weighing 200e240 g were housed in con-
ventional cages with free access to water and rodent chow at
20e22C with a 12-hour lightedark cycle. All procedures
involving laboratory animal use were in accordance with the
guidelines of the Instituted Animal Care and Use Committee
of Chung Shan Medical University (Taichung, Taiwan, R.O.C.)
for the care and use of laboratory animals. The experimental
setting is Group A were treated with olive oil (1.0 mL/kg) by
intraperitoneal injection, and Groups BeE were treated with
8% CCl4/olive oil (1.0mL/kg) by intraperitoneal injection, twice
every week (Monday and Thursday) for 8 weeks, as described
by Herna´ndez-Mun˜oz et al [33] with some modifications. On
Tuesday, Wednesday, Friday, and Saturday, Groups A and B
were treated with water, Groups C and D were treated with
low dose (100 mg/kg) and high dose (200 mg/kg) of CCTEP,
respectively, and Group E was treated with silymarin (200 mg/
kg); all by oral gavage. The mortality rate and body weight
were recorded daily. At the end of the experiment, blood and
organs were immediately collected after the animals were
sacrificed. Liver tissue samples were taken from the left liver
lobe and cut into two pieces. One piece was fixed in formalin
for pathological examination. The other piece was subjected
to biological analyses. The blood samples and organ tissues
were all collected and stored at 80C until use.2.3. Biochemical assays of serum
All biochemical assays were conducted in the clinical labora-
tories of the Kuang Tien General Hospital, Taichung, Taiwan.
The levels of aspartate transaminase (AST) and alanine
transaminase (ALT) were measured on a Beckman Coulter
Synchron Clinical Systems Analyzer (LX20PRO Autoanalyzer;
Beckman Coulter Inc., Taipei, Taiwan). Specifically, AST was
measured by an oxaloacetate/malate dehydrogenase method,
whereas ALT was measured by a pyruvate/lactate dehydro-
genase method. Serum total cholesterol and triglyceride were
measured on a Hitachi 7170 autoanalyzer (Hitachi, Tokyo,
Japan).2.4. Preparation of liver homogenate and assay of
protein content
A 1 g sample of liver tissue in 10 mL ice-cold potassium
phosphate buffer (pH 7.0) was homogenized in an IKA-WEAR
homogenizer (RW 20 DZM; IKA, Staufen, Germany). The
homogenate solution was centrifuged at 12,000g for 30 mi-
nutes. The supernatant was collected and stored at 80C for
protein content assay, GSH and the antioxidant enzyme ac-
tivities in the liver. The supernatant was collected and
assayed for protein content by the Bradford method, using aprotein assay kit supplied by Bio-Rad (Bio-Rad Laboratories,
Hercules, CA, USA), with bovine serum albumin as a standard.2.5. Determination of GSH in the liver
GSH was determined by titration with 5,50-dithiobis-2-
nitrobenzoic acid (DTNB, Ellman’s reagent) [34] as described
previously [35], with some modifications. Proteins of 0.4 mL
liver homogenates were precipitated by the addition of 0.4 mL
a metaphosphoric acid solution (1.67 g metaphosphoric acid,
0.20 g EDTA, and 30.0 g NaCl in 100 mL H2O). After 40 minutes,
the protein precipitate was recovered by centrifugation at
12,000g in a microcentrifuge (Microfuge; Beckman) at 4C for
30minutes. A 100 mL aliquot of the supernatant was combined
with 0.7 mL 300 mM Na2HPO4, and the absorbance at 412 nm
was read against a blank consisting of 0.1mL supernatant plus
0.7 mL H2O. A 100 mL aliquot of DTNB (0.02%, w/v 1% sodium
citrate) was then added to the blank and sample. Absorbance
of the sample was read against the blank at 412 nm. The GSH
content was determined using a calibration curve prepared
with an authentic sample. An aliquot of lysate was used for
the determination of protein content. GSH values are
expressed as nmol/mg protein.2.6. CAT assay
CAT activity was measured by the method of Kawamura et al
[36]: 0.1 mL supernatant was added to cuvette containing
1.9 mL 50 mM phosphate buffer (pH 7.0). Reaction was started
by adding 1.0 mL freshly prepared 30 mM H2O2. The rate of
decomposition of H2O2 was measured spectrophotometrically
at 240 nm. Activity of CAT was expressed as U/mg of protein.2.7. Histopathologic study
A portion of the liver was fixed in 10% formalin, processed
using routine histology procedures, embedded in paraffin, cut
in 5 mm sections, and mounted on a slide. The sections were
then stained with hematoxylineeosin dye and studied for
histopathological changes (40), i.e., necrosis, fatty changes,
ballooning degeneration, and lymphocyte infiltration. Masson
stain was used for liver steatosis and fibrosis scoring. Liver
steatosis was graded on a 3-point scale: 1þ, hepatocytes in the
area of one-third of the lobules showing fatty accumulation;
2þ, for two-thirds; and 3þ, for all hepatocytes. The criteria
used for scoring fibrosis severity were as follows: 0, normal;
1þ, fibrosis present (collagen fiber present that extends from
portal triad or central vein to peripheral region); 2þ, mild
fibrosis (collagen fiber present with extension without
compartment formation); 3þ, moderate fibrosis (collagen fiber
present with some pseudo lobe formation); and 4þ, severe
fibrosis (collagen fiber present with thickening of the partial
compartments and frequent pseudo lobe formation).2.8. Statistical analysis
The experimental results are expressed as the
mean  standard deviation. Data were assessed using anal-
ysis of variance (ANOVA). Student t test was used in the
Table 1 e The effects of Chhit-Chan-Than extract powder
on the ratio of organ to body weight (BW) in CCl4-induced
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statistically significant.liver injury rats.
Group Ratio of
liver to BW
Ratio of spleen
to BW
Ratio of
kidney to BW
A 2.63  0.04 0.20  0.02 0.67  0.02
B 3.79  0.12* 0.25  0.02 0.85  0.09**
C 3.33  0.21** 0.22  0.03 0.68  0.01***
D 3.09  0.11*** 0.21  0.01 0.70  0.03***
E 3.39  0.31** 0.21  0.01 0.74  0.00
The ratios of organ to body weight are expressed as mean  SE,
n ¼ 8.
*p < 0.01 as compared with the control group.
**p < 0.05 as compared with the control group.
***p < 0.05 as compared with the CCl4 only group.
A ¼ control group; B ¼ CCl4-treated group; C ¼ CCl4- and 100 mg/kg
Chhit-Chan-Than extract powder-treated group; D ¼ CCl4- and
200 mg/kg Chhit-Chan-Than extract powder-treated group; E ¼ CCl4-
and 200 mg/kg silymarin-treated group.3. Results
3.1. Clinic observation, body weight, and organ weight
change
No dead rat was observed during the 8-week test of hep-
aprotective effect of CCTEP. However, in the CCl4-treated only
group the rats look emaciated at Week 7 or Week 8, possibly
due to the liver damage.
The change of body weight may be in response to the rat
growth rate and physiologic conditions. Fig. 1 shows the
change of body weight during the 8-week test of hep-
atoprotective effect of CCTEP. The CCl4-treated control group
rats (B, average weight 382.1  53.9 g) had a reduced mean
body weight (p < 0.01) as compared with those of normal
control group (A, weight 440.8  35.0 g). The weight gain in
Group A (240.8 25.8 g) administrated with olive oil and water
was the most obvious, but is small in Group B (average
180.0  37.1 g) administrated with CCl4. In the interventional
groups, supplement of silymarin or CCTEP with CCl4 did not
adequately resume the lost weight caused by CCl4. In Group C
(440.0  12.9 g), Group D (392.1  19.1 9), and Group E
(398.3  41.3 g) administrated with different dose of CCTEP
and silymarin, the scope of weight gain has restored, but was
not statistically significant.Fig. 1 e Effects of Chhit-Chan-Than extract powder (CCTEP)
on body weight after CCl4 treatment in rats. CCTEP and
CCl4 were given as described in “Methods”. (A) Normal
control group; (B) CCl4-treated control group; (C) CCl4- and
100 mg/kg CCTEP-treated group; (D) CCl4- and 200 mg/kg
CCTEP-treated group; and (E) CCl4- and 200 mg/kg
silymarin-treated group. Data are presented as
mean ± standard deviation, n [ 8. *p< 0.05 as compared
with the normal control group.After the final experiment, the rats were sacrificed, and the
liver, kidney, and spleenwereweighed. Table 1 shows that the
ratio of organ weight in Group B increased, but has restored in
Groups CeE. The ratio of liver weight to body weight in Group
B significantly increased as compared with Group A (p < 0.01),
whereas that in Groups C and D also slightly increased
(p < 0.05). However, in Group D, the ratio of liver weight to
bodyweight restored as comparedwith Group B (p< 0.05). The
ratio of kidney weight to body weight in Group B significantly
increased as comparedwith GroupA (p< 0.05), and restored in
Groups C and D (p < 0.05). The ratio of spleen weight to body
weight did not show any remarkable difference in each group.3.2. Serum biochemistry examination
Measurements of serum biochemical markers were taken at
the end of the experiment. Fig. 2 shows that the levels of tri-
glycerine and cholesterol did not alter in all groups at 8 weeks.
AST and ALT in the CCl4-treated group increased markedly to
761  149 U/L and 788  148 U/L as compared with the control
group at 46  10 U/L and 151  45 U/L, respectively. When
cotreated with 100 mg/kg CCTEP, 200 mg/kg CCTEP (Fig. 2), or
200 mg/kg silymarin, the AST levels were restored to
583  128 U/L, 440  50 U/L, and 522  267 U/L, respectively,
whereas the corresponding ALT levels were restored to
504  98 U/L, 525  76 U/L, and 500  196 U/L, respectively.3.3. Anti-oxidative enzyme activity
Effects of CCTEP on hepatic CAT and GSH levels for all
experimental groups are shown in Table 2. CCl4 treatment
caused a significant decrease of GSH level in liver tissue ho-
mogenates compared with the normal group. Pretreatment of
100 mg/kg CCTEP (C) enhanced the level of GSH compared
with CCl4-treated group. Treatmentwith CCTEP (200mg/kg, D)
prior to the CCl4 treatment elevated the GSH level. Similar
results were obtained with silymarin (200 mg/kg, E).
The activity of liver CAT in the CCl4 treated rats (Group B)
decreased significantly as compared with the control (Group
Fig. 2 e The effects of Chhit-Chan-Than extract powder on serum AST, ALP, TG, and cholesterol in rats treated with CCl4 for 8
weeks. Chhit-Chan-Than extract powder and CCl4 were given as described in “Methods”. Data are presented as
mean ± standard deviation, n[ 8. *p< 0.05 as compared with the normal control group. ALT[ alanine amino transferase;
AST [ aspartamine amino transferase; Cho [ cholesterol; TG [ triglyceride.
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rats treated with CCTEP (100 mg/kg, Group C), CCTEP (200 mg/
kg, Group D), and the silymarin (200 mg/kg, Group E).3.4. Histopathologic study
The general liver morphological changes and fibrosis induced
by CCl4 administration were evidenced by both qualitative
and quantitative histopathological examination. As compared
with the normal rat liver, the tissue section in Figs. 3 and 4
show that the CCl4-induced chronic liver injury was concave
on the liver surface and had lymphocyte infiltration in theTable 2 e Effects of Chhit-Chan-Than extract powder on
the liver glutathione levels and catalase activity after
CCl4-treated in rats.
a
Group Glutathione
(nmol/mg protein)
Catalase activity
(IU/mg protein)
A 7.7  0.4 8.2  1.6
B 5.8  0.4** 4.6  0.1*
C 8.7  0.9**** 5.4  0.3**,****
D 9.1  0.4**** 6.1  0.3***
E 8.8  0.9**** 5.3  0.2**,****
The liver GSH value and catalase activity are expressed as
mean  SE, n ¼ 8.
*p < 0.01 as compared with the control group.
**p < 0.05 as compared with the control group.
***p < 0.01 as compared with the CCl4-treated group.
****p < 0.05 as compared with the CCl4-treated group.
A ¼ control group; B ¼ CCl4-treated group; C ¼ CCl4- and 100 mg/kg
Chhit-Chan-Than extract powder-treated group; D ¼ CCl4- and
200 mg/kg Chhit-Chan-Than extract powder-treated group; E ¼ CCl4-
and 200 mg/kg silymarin-treated group.
a Chhit-Chan-Than extract powder and CCl4 are given as described
in “Methods” in the main text.central vein. The hepatic cells were found to be cloudy,
swelling, and necrotic, cytoplasmic vacuolization and fatty
degenerationwere observed in the centrilobular zone andmid
zone. Masson trichrome stain clearly demonstrated that the
CCl4-intoxicated liver became fibrotic with fiber extension and
collagen accumulation (Fig. 5). These pathological changes
(such as fibrosis and inflammation) were ameliorated by
cotreatment of silymarin or CCTEP, which showed a dose-
dependent effect (Figs. 4 and 5). The severity of the liver
morphological changes and fibrosis induced by CCl4 treatment
were scored and summarized in Table 3. As shown, four out of
eight CCl4-exposed rats had liver morphological change
greater than Grade 3þ, and five out of eight had liver fibrosis
and necrosis greater than Grade 2. The CCTEP exposure
greatly improved liver morphological changes, fibrosis, and
necrosis. The average severity scores of the CCTEP-treated
rats were markedly reduced in a dose-dependent manner.4. Discussion
CCl4 has been widely used in animal models to investigate
chemical toxin-induced liver damage and as an excellent
model to evaluate the efficacy of hepatoprotectants [37e39].
The ability of a hepatoprotective drug to reduce the injurious
effects or to preserve the normal hepatic physiological
mechanisms that have been disturbed by a hepatotoxin, is the
index of its protective effects [40]. The purpose of this research
program is to evaluate the hepaprotective effects of CCTEP in
CCl4-induced liver damage in Wistar rats. In this study, rats
treated with CCl4 developed significant hepatic damage as
manifested by a significant increase in plasma activities of
AST and ALT, which are indicators of hepatocyte damage and
loss of functional integrity. The CCTEP treatment stimulated
hepatoprotective effects that were proven by attenuating
Fig. 3 e Livers from CCl4- and/or Chhit-Chan-Than extract powder (CCTEP)-treated rats. CCTEP and CCl4 were given as
described in “Methods”. (A) Normal control group; (B) CCl4-treated control group; (C) CCl4- and 100 mg/kg CCTEP-treated
group; (D) CCl4- and 200 mg/kg CCTEP-treated group; and (E) CCl4- and 200 mg/kg silymarin-treated group.
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CCTEP can ameliorate oxidative stress contributing to the
amount of intracellular antioxidant enzymes, which was
confirmed by GSH and CAT assay. Centrilobular necrosis,
lymphocytes infiltration and steatosis were apparent in CCl4-
treated group, whereas administration of the CCTEP signifi-
cantly reverses these abnormal indexes. This indicates that
CCTEP can ameliorate oxidative stress to preserve hepatic
function and hepatic injury induced by CCl4.
Free radicals/reactive oxygen species (ROS) and oxidative
stress play a central role in liver disease pathology and pro-
gression [1,2]. Cellular injury occurs when ROS generation
exceeds the cellular capacity of removal [41]. The cleavage of
CCl4 leads to the formation of highly unstable free radicals
(CCl3 or CCl3O2), to initiate peroxidation [26]. The oxidant
species may in turn trigger the signal transduction pathwaysFig. 4 e Effects of Chhit-Chan-Than extract powder (CCTEP) on li
CCl4 treatment in rats. CCTEP and CCl4 were given as described
control group; (C) CCl4- and 100 mg/kg CCTEP-treated group; (D)
200 mg/kg silymarin-treated group (original magnification: 403involved in the antioxidant responses. Antioxidant enzymes
(CAT, superoxide dismutase, glutathione peroxidase, etc.)
represent one protection system against oxidative tissue-
damage [42]. CAT is known to break H2O2 down to H2O and
O2 and can be found in the peroxisome and mitochondria,
especially in liver. Superoxide dismutase removes superoxide
radicals by converting them into H2O2, which, in turn, can be
rapidly converted into water by catalase and glutathione
peroxidase. Thus, the inhibition of free radicals generation
retards CCl4-induced lipid peroxidation. In the present study,
antioxidant enzymes activities in the liver of CCl4-treated
group rats were significantly lower than those in the normal
control group. Previous studies have indicated that CCl4 re-
duces the activities of antioxidant enzymes and causes hep-
atopathy [26]. Interestingly, impaired hepatic antioxidant
enzymes activities were brought back via the treatment ofver pathologic analysis by hematoxylineeosin stain after
in “Methods”. (A) Normal control group; (B) CCl4-treated
CCl4- and 200 mg/kg CCTEP-treated group; and (E) CCl4- and
).
Fig. 5 e Effects of Chhit-Chan-Than extract powder (CCTEP) on liver pathologic analysis by Masson’s stain after CCl4
treatment in rats. CCTEP and CCl4 were given as described in “Methods”. (A) Normal control group; (B) CCl4-treated control
group; (C) CCl4- and 100mg/kg CCTEP-treated group; (D) CCl4- and 200mg/kg CCTEP-treated group; and (E) CCl4- and 200mg/
kg silymarin-treated group.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 2 ( 2 0 1 4 ) 2 2 0e2 2 9226CCTEP to CCl4-treated rats. Our present works clearly showed
an elevation of CAT level in liver, suggesting that it can restore
these antioxidant enzymes and/or activate enzyme activity in
the damage caused by CCl4.
GSH is believed to be a highly effective extra- and intra-
cellular antioxidant compound that neutralizes H2O2 and hy-
droperoxides by its scavenging and antioxidant properties
[43]. In this study, GSH content in the liver of CCl4-intoxi-
cated rats was declined by CCl4 treatment and its subsequent
enhancement revealed antioxidant effects of CCTEP. A num-
ber of studies have revealed that GSH conjugates play a major
role in eliminating the CCl4-induced toxic metabolites that are
themain cause of liver injuries. Themaintenance of sufficient
glutathione level is important for the prevention of CCl4-
induced damages. Toxicants that deplete GSH or influence theTable 3 e The effects of Chhit-Chan-Than extract powder on his
Group Severity score of fatty metamorphosis (incidence)
N 0 1 2 3 Mean  SE
A 8 8 0 0 0 0.0  0.0
B 8 1 2 1 4 2.0  0.4*
C 8 1 1 3 3 2.0  0.4*
D 8 3 3 2 0 2.0  0.4*
E 8 2 4 2 0 1.0  0.3*
Data represent the number of rats rated with a given level of fatty me
additional details.
*p < 0.01 as compared with the control group.
**p < 0.05.
***p < 0.01 as compared with the CCl4 only group by the Student t test.
****p < 0.05.
SE ¼ standard error.
a Chhit-Chan-Than extract powder and CCl4 are given as described in “Meactivity of GSH-dependent enzyme(s) may result in toxic re-
sponses. The study herein presented was instigated by other
reports [44] where CCl4 administration caused depletion in
GSH contents. The mechanism of hepatoprotection by CCTEP
against the CCl4 toxicity might be partially due to the resto-
ration of GSH concentration in liver.
CCl4 is metabolized by cytochrome P450 2E1 to the tri-
chloromethyl radical (CCl3), which is assumed to initiate free
radical-mediated lipid peroxidation leading to the accumula-
tion of lipid-derived oxidation products that cause liver injury
[45]. Alternatively, oxidative stress generated from cyto-
chrome P450-catalyzed metabolism of xenobiotics can result
in protective cellular responses, leading to the enhancement
of cell survival upon noxious stimuli [46]. Studies have indi-
cated that some phytochemicals are found to regulatetopathological evidence of CCl4-induced liver fibrosis rats.
a
Severity score of fatty hepatic fibrosis (incidence)
0 1 2 3 4 Mean  SE
8 0 0 0 0 0.0  0.0
0 1 4 3 0 2.3  0.3*,****
2 4 2 0 0 1.0  0.3*,****
5 2 1 0 0 0.5  0.3***
4 3 1 0 0 0.6  0.3**,***
tamorphosis or hepatic fibrosis; see “Methods” in the main text for
thods” in the main text.
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effects, especially on the specific protein activity by mRNA
expression [47,48]. The present study has found that CCTEP
contributes to the amount of catalase and GSH inside the liver
after chronic CCl4 treatment (Table 2). Catalase is known to
breakdown H2O2, the downstream product of free radical
metabolic cascade, and thus protect liver from oxidative
stress. In a previous study, we clearly demonstrated in vitro
OGE’s powerful antioxidant activity with 80% scavenging ef-
fect, which is as effective as a-tocopherol, as well as lowing
thiobarituric acid-reactive substances (TBARS) in H2O2-treated
HepG2 cells [21]. Taken together with the present study, it can
therefore be claimed that CCTEP lowers oxidative stress-
induced liver injury by increasing antioxidants inside the
liver. Induction of GSH levels may be due to the activation of
GSH synthesizing enzymes such as g-glutamylcysteine syn-
thetase and GSH synthetase, which are key enzymes in the
biosynthesis of GSH [49]. These results could indicate that
CCTEP either inhibits ROS induced lipid peroxidation, or
directly lowers ROS production, possibly through the inhibi-
tion of CYP2E1 activity. Some antioxidants, such as Vitamin C
and E or garlic acid, are shown to possess similar mechanisms
[50,51].
For the therapeutic strategies of liver injury and disease, it
is important to find antioxidant compounds that are able to
block liver injuries through free radicals generated by toxic
chemicals. Therefore, the present study speculated that the
aqueous O. gratissimum extract protects against diseases that
are caused by oxidative stress because it is rich in polyphenols
and has excellent radical scavenging ability. Our preliminary
phytochemical screening discovered a significant quantity of
simple phenols and flavonoids inside OGE, including catechin,
caffeic acid, epicatechin, and rutin [12,16,20,29]. Other re-
searchers have reported that green tea catechin is capable of
inhibiting the activation of hepatic stellate cells (HSCs), which
leads to liver fibrosis by lowering the secretion of liver fibril-
forming collagen [52], rutin is capable of lowering liver
oxidative damage [53e55], and caffeic acid is capable of
treating liver cirrhosis by suppressing H2O2 formation [56].
Primarily, the hepatoprotective effects of these phytocon-
stituents may inhibit lipid peroxidation in the liver, which
suggests that it may prevent free radical damage and thus
protect the liver from oxidative stress [57].
In the present study, although CCTEP could not completely
repair the hepatic injury induced by CCl4, it is possible that the
CCl4 dose at the late stage was too high so that the liver
damage could not be restored. The trend of protective effects
on AST and ALT levels between CCl4-control group (Group B)
and interventional groups (Groups CeE) is clearly demon-
strated in Fig. 2 and described in the Section 3.2. “Serum
biochemistry examination”. However, the evident reduction
of values cannot reach significance by ANOVA analysis (due to
the small experimental animal number and data variance).
Thus, the transaminase-restored effects of CCTEP and sily-
marin were hard to clarify completely in this study. Fortu-
nately, the diagnostic value of histopathologic morphology in
long-term hepatic injury is more meaningful than that of AST
or ALT in the acute stage. In a chronic CCl4-treated rat model,
progressive scarring of the liver (fibrogenesis) is characterized
by an excessive deposition of extracellular matrix (ECM)proteins (predominantly types I and III collagen) due to the
activation of HSCs. Our laboratory also demonstrated that
OGE possesses an antiliver fibrosis property by inhibiting
in vitro HSCs activation, as well as effectively suppressing the
expression of a-smoothmuscle actin and type I collagen using
an in vivo model (unpublished data).
CCTEP used in this studywas developed from aqueous OGE
for further commercial products such as oral capsules or
beverage power package. The powderwasmadewith 10%OGE
and 90% dextrin as an excipient. Several products and phy-
toconstituents deriving from O. gratissimum have been inves-
tigated by different models and protocols in vitro or in vivo in
our laboratory [12,16,20,21,29,58]. The hepatoprotective effi-
cacy of OGE has already been reported by our research group
[21,29], as well as the proposal molecular mechanisms [29].
The motive of the present study was to explore the newly-
developed product with similar protective property, but less
molecular mechanism is discussed. The hepatoprotective ef-
fects of O. gratissimum extract were associated not only with
antioxidative mechanisms but also with inflammatory path-
ways, cell death pathways, and activation of HSCs, which are
discussed elsewhere. Our previous works [29] demonstrated
the beneficial effects of OGE in acute hepatic injury in vivo and
found that significantly decreased stress proteins including
HSP70 and iNOS were observed. The antioxidant activities of
OGE can directly ameliorate oxidative stress by inhibiting lipid
peroxidation and contributing to the levels of intracellular
antioxidant enzymes, which were confirmed by TBARS assay
and antioxidant assay (unpublished data). The cytoprotective
property may also be achieved by regulating Bcl-2 expression
and Akt phosphorylation, and slightly affecting the phos-
phorylation of mitogen-activated protein kinases including
p38MAPK and JNK that reduce proinflammatory mechanisms
[12,21].
Studies indicate that different doses of drugs may have
different physiologic or pharmacologic effects [59], and low
doses may be ineffective due to low absorption in the
gastrointestinal tract [60]. Previous studies have established
that silymarin, the current leading hepatoprotective herbal
extract, works best at 0.2 g/kg body weight [6,61]. By contrast,
another study has shown that silymarin failed to reverse
fibrosis significantly, which was previously established by
prolonged chronic CCl4 administration in ratswhen compared
with an appropriate vehicle control [62]. This difference in
results may be due to the diverse doses of herbal extract used.
Previous studies reported that dried flower Hibiscus sabdariffa
L. extract treatment works ideally by being mixed in with a
regular diet at 5% of the diet [63], aqueous extract of Anoecto-
chilus formosanus has been reported to work at 2.0 g/kg body
weight [64], and Ginkgo biloba extract has shown promising
results at 0.5 g/kg body weight [65]. In the present study, the
suppression of CCTEP at 200mg/kg bodyweight was similar to
that of silymarin at the same dose. This demonstrates the
potency of CCTEP and suggests that O. gratissimum may have
the potential to be an herb choice in the treatment of chronic
liver disease.
In conclusion, the present study showed that CCTEP (10%
aqueous O. gratissimum L. extract) has a remarkable protective
effect against CCl4-induced liver damage. The micronutrient
functions of O. gratissimummay be as an effecter of important
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 2 ( 2 0 1 4 ) 2 2 0e2 2 9228cellular stress response pathways that ultimately influence
endogenous cellular antioxidant levels. The inhibitory effects
of CCTEP may have therapeutic achievements in chemical-
induced hepatic injury in vivo, and thus dietary CCTEP may
be useful as a hepatoprotective agent against chronic liver
disease in humans.
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